Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

The Characteristics of Electrocardiography Findings in Left Ventricular Remodeling Patterns of Hypertensive Patients

  • Received : 2015.11.01
  • Accepted : 2015.11.17
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The exact diagnosis of left ventricular hypertrophy (LVH) is very important in the treatment of hypertension. The purpose of our study is to determine the relationship between left ventricular remodeling patterns and electrocardiography (ECG) findings in hypertensive patients. We divided 137 patients into four groups according to left ventricular mass index (LVMI) and the relative wall thickness: normal, concentric remodeling, concentric hypertrophy, eccentric hypertrophy. LVH on the ECG was defined by three ECG criteria: Sokolow-Lyon voltage criteria, Cornell voltage criteria and Romhilt-Estes point score. LVH on the echocardiography was defined by LVMI. The prevalence of ECG LVH was increased in concentric hypertrophy and eccentric hypertrophy group. The QRS voltages by Sokolow-Lyon voltage criteria (r = 0.494, P = 0.002) and Cornell voltage criteria (r = 0.628, P < 0.001), and Romhilt-Estes point score (r = 0.689, P < 0.001) were positively correlated with LVMI. Also, the QRS voltages and point scores were significantly increased in the concentric hypertrophy and eccentric hypertrophy group with increased LVMI. The QRS voltage and Romhilt-Estes point scores were positively correlated with LVMI. The QRS voltages and Romhilt-Estes point scores were also increased in the left ventricular remodeling groups with increased LVMI.

Keywords

References

  1. Ahn MS, Yoo BS, Lee JH, Lee JW, Youn YJ, Ahn SG, Kim JY, Lee SH, Yoon JH, Choe KH, Koh SB, Ahn SV, Park JK. The Accuracy of Electrocardiogram Criteria for Left Ventricular Hypertrophy in Korean Cohort (Atherosclerosis Risk of a Rural Area Korean General Population). J Korean Soc Hypertens. 2013. 19: 112-122. https://doi.org/10.5646/jksh.2013.19.4.112
  2. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015. 38 Suppl: S8-S16.
  3. Budhwani N, Patel S, Dwyer EM Jr. Electrocardiographic diagnosis of left ventricular hypertrophy: The effect of left ventricular wall thickness, size, and mass on the specific criteria for left ventricular hypertrophy. Am Heart J. 2005. 149: 709-714. https://doi.org/10.1016/j.ahj.2004.07.040
  4. Casiglia E, Schiavon L, Tikhonoff V, Bascelli A, Martini B, Mazza A, Caffi S, D'Este D, Bagato F, Bolzon M, Guidotti F, Haxhi Nasto H, Saugo M, Guglielmi F, Pessina AC. Electrocardiographic criteria of left ventricular hypertrophy in general population. Eur J Epidemiol. 2008. 23: 261-271. https://doi.org/10.1007/s10654-008-9234-6
  5. Chiang BN, Perlman LV, Fulton M, Ostrander LD Jr, Epstein FH. Predisposing factors in sudden death in Tecumseh, Michigan. A prospective study. Circulation. 1970. 41: 31-37. https://doi.org/10.1161/01.CIR.41.1.31
  6. Devereux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implication. J Hypertens Suppl. 1994. 12: S117-127.
  7. Devereux RB, Anlonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachos I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy comparion to necropsy findings. Am J Cardiol. 1986. 57: 450-458. https://doi.org/10.1016/0002-9149(86)90771-X
  8. Grossman W, Jones D, McLaurin LP. Wall stress and pattern of hypertrophy in the human left ventricle. J Clin Invest. 1975. 56: 56-64. https://doi.org/10.1172/JCI108079
  9. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992. 19: 1550-1558. https://doi.org/10.1016/0735-1097(92)90617-V
  10. Korea MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991. 144: 345-352.
  11. Kligfield P, Gettes LS, Bailey JJ, Childers R, Deal BJ, Hancock EW, van Herpen G, Kors JA, Macfarlane P, Mirvis DM, Pahlm O, Rautaharju P, Wagner GS; American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society, Josephson M, Mason JW, Okin P, Surawicz B, Wellens H. Recommendations for the standardization and interpretation of the electrocardiogram: Part I: The electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2007. 115: 1306-1324.
  12. Levy D, Garrion RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in and elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989. 110: 101-107. https://doi.org/10.7326/0003-4819-110-2-101
  13. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Ehcocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 1988. 108: 7-13. https://doi.org/10.7326/0003-4819-108-1-7
  14. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and speificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990a. 81: 815-820. https://doi.org/10.1161/01.CIR.81.3.815
  15. Levy D, Grrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990b. 322: 1561-1566. https://doi.org/10.1056/NEJM199005313222203
  16. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001. 104: 1615-1621. https://doi.org/10.1161/hc3901.096700
  17. Molloy JM, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol. 1992. 5: 1180-1186.
  18. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlof B. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan intervention For End point. J Am Coll Cardiol. 2001. 38: 514-520. https://doi.org/10.1016/S0735-1097(01)01378-X
  19. Okin PM, Devereux RB, Liu JE, Oikarinen L, Jern S, Kjeldsen SE, Julius S, Wachtell K, Nieminen MS, Dahlof B. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE Study. J Hum Hypertens. 2004b. 18: 403-409. https://doi.org/10.1038/sj.jhh.1001707
  20. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlof B. LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004a. 292: 2343-2349. https://doi.org/10.1001/jama.292.19.2343
  21. Prineas RJ, Rautaharju PM, Grandits G, Crow R. MRFIT Research Group. Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the Multiple Risk Factor Intervention Trial. J Electrocardiol. 2001. 34: 91-101. https://doi.org/10.1054/jelc.2001.23360
  22. Radulescu D, Pripon S, Parv A, Duncea C, Gulei I. Electrocardiography and conventional radiology accuracy compared to echocardiography in evaluating left ventricular remodelling patterns in hypertensive patients. Panminerva Med. 2008. 50: 97-103.
  23. Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968. 75: 752-758. https://doi.org/10.1016/0002-8703(68)90035-5
  24. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantification in M-mode echocardiography results of a survey of echocariographic measurements. Circulation. 1978. 58: 1072-1083. https://doi.org/10.1161/01.CIR.58.6.1072
  25. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000. 35: 580-586. https://doi.org/10.1161/01.HYP.35.2.580
  26. Siegel D, Cheitlin MD, Black DM, Seeley D, Hearst N, Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol. 1990. 65: 742-747. https://doi.org/10.1016/0002-9149(90)91381-F
  27. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949. 37: 161-186. https://doi.org/10.1016/0002-8703(49)90562-1
  28. Son JI, Chin SO, Woo JT, and The Committee for Developing Treatment Guidelines for Dyslipidemia, Korean Society of Lipidology and Atherosclerosis (KSLA). J Lipid Atheroscler. 2012. 1: 45-59. https://doi.org/10.12997/jla.2012.1.2.45
  29. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy. J Am Coll Cardiol. 1998. 31: 383-390. https://doi.org/10.1016/S0735-1097(97)85372-7